Quantum-Si Reports Q3 2026 Results Amid Transition to Proteus Platform
Quantum-Si (QSI) reported third-quarter 2026 revenue of $212,000, a significant decrease from $552,000 in the prior year. This decline is attributed to a planned strategic transition from the company's Platinum Pro platform to its next-generation Proteus sequencing technology. Despite lower revenue, the company narrowed its net loss to $22.3 million, down from a $35.7 million loss in Q3 2025, driven by aggressive expense management and restructuring efforts. The company is focusing on the commercial launch of Proteus, scheduled for Q2 2027, which boasts a 30-fold increase in sequencing output per chamber and an 80% reduction in error rates compared to previous technology. To preserve capital, Quantum-Si implemented a 20% workforce reduction expected to yield $12 million in annual savings. Management maintains that its current cash position of $149.4 million is sufficient to fund operations through the fourth quarter of 2028.
Coverage
- Quantum-Si Reports Q3 2026 Results Amid Transition to Proteus Platform
- The Joint Corp. Reports Q3 2026 Results Amid Transition to Franchisor Model
- Solventum Reports Q3 2026 Results Impacted by ERP Transition and Order Reversals
- Quantum-Si outlines Proteus launch in Q2 2027 while lowering 2026 adjusted OpEx guidance to $87M or less
- Quantum-Si Announces Proteus Launch Timeline for Q2 2027 and Reduces 2026 OpEx Guidance